Apply for funding
Cure Parkinson’s funds both preclinical and clinical research projects that have the potential to cure Parkinson’s.
By “cure”, we mean “disease-modifying” therapies that potentially slow, stop or reverse the disease progression of Parkinson’s. In addition, we prioritise research which has the potential to translate into the clinic within five years.
Our funding programmes
Quarterly Research Grant Funding Programme
This programme primarily funds preclinical and clinical research focused on disease modification to slow, stop, or reverse Parkinson’s. For preclinical research, projects that could lead to clinical trials in Parkinson’s within 5 years are prioritised. We only fund clinical research in people with Parkinson’s.
New: Combination therapies funding call
Our new £2 million funding call welcomes both preclinical and clinical applications from around the globe to test rationally designed combinations of two or more drugs for disease modification in Parkinson’s. We will be accepting expressions of interest for funding from Wednesday 1 October until Monday 24 November.
